Kurt Hilpert

This inventor holds 44 USPTO granted patents and 3 published patent applications, plus 15 CIPO patents and 17 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Actelion Pharmaceuticals Ltd, Hoffmann-La Roche Inc., Idorsia Pharmaceuticals Ltd. Active years: 1993-2017.

USPTO Granted Patents = 44 (Patent Applications = 3)

% Patents Active = 56.8

CIPO Patents = 15

EPO Patents = 17 (Patent Applications = 16)

Average Co-Inventor Count = 5.1

ph-index = 8

Forward Citations = 275(Granted Patents)

Location History:

Hofstetten, CH (1993 - 2016)
Allschwil, CH (2012 - 2017)

Company Filing History:

22 out of 217

Actelion Pharmaceuticals Ltd

patents

21 out of 5,016

Hoffmann-La Roche Inc.

patents

1 out of 80

Idorsia Pharmaceuticals Ltd

patents

Years Active: 1993-2017

Loading Chart...

Areas of Expertise:

P2X7 Receptor Antagonists

Thiazole Derivatives

Guanidine Derivatives

Heterocyclic Amides

P2Y12 Receptor Antagonists

Indole Derivatives

Pyrimidine Derivatives

Sulfonamidocarboxamides

Tetrahydronaphthalene

Neuropeptide FF Receptor

Carbonyl-Pyridine

Bridged Compounds

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9718774 - Indole carboxamide derivatives as P2X7 receptor antagonist (2017-08-01),

2. 9556117 - [object Object] (2017-01-31),

3. 9409917 - Heterocyclic amide derivatives as P2X7 receptor antagonists (2016-08-09),

4. 9388198 - [object Object] (2016-07-12),

5. 9388197 - Heterocyclic amide derivatives as P2X7 receptor antagonists (2016-07-12),

6. 9221832 - Heterocyclic amide derivatives as P2X7 receptor antagonists (2015-12-29),

7. 8664203 - Thiazole derivatives and their use as P2Y12 receptor antagonists (2014-03-04),

8. 8518912 - [object Object] (2013-08-27),

9. 8492555 - Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester (2013-07-23),

10. 8436205 - Tetrahydronaphthalene compounds (2013-05-07),

11. 8314253 - Bridged tetrahydronaphthalene derivatives (2012-11-20),

12. 8288385 - 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines (2012-10-16),

13. 8273740 - 2-sulfanyl-benzoimidazol-1-yi-acetic acid derivatives as CRTH2 antagonists (2012-09-25),

14. 8202885 - Bridged six-membered ring compounds (2012-06-19),

15. 8093250 - 2-aminocarbonyl-pyridine derivatives (2012-01-10),

Title: Kurt Hilpert - Innovative Inventor from Hofstetten

Introduction: Kurt Hilpert is a renowned inventor hailing from Hofstetten, Switzerland, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Kurt Hilpert holds several patents in the areas of renewable energy, sustainable agriculture, and advanced materials, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With over two decades of experience in research and development, Kurt Hilpert has worked with leading companies and research institutions to bring cutting-edge technologies to life. His passion for pushing the boundaries of what is possible has led to the creation of numerous revolutionary inventions.

Collaborations: Throughout his career, Kurt Hilpert has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of creativity and excellence. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Kurt Hilpert's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His impact on the world of technology and science is undeniable, and his legacy will continue to inspire future generations of inventors.